カテゴリ： 世界, 医療/バイオ, Market Monitor Global

がん再発モニタリングキットのグローバル市場展望 2023年-2029年：血液がん、骨がん

■ 英語タイトル：Cancer Recurrence Monitoring Kit Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12725）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12725
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：119
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[がん再発モニタリングキットのグローバル市場展望 2023年-2029年：血液がん、骨がん]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のがん再発モニタリングキット市場規模と予測を収録しています。・世界のがん再発モニタリングキット市場：売上、2018年-2023年、2024年-2029年
・世界のがん再発モニタリングキット市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のがん再発モニタリングキット市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「血液がん」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

がん再発モニタリングキットのグローバル主要企業は、SeekIn、 Guardant Health、 Neoimmune、 Labcorp Inc、 F.Hoffmann-La Roche Ltd.、 Cergentis B.V.、 Sysmex Corporation、 NeoGenomics Laboratories, Inc.、 Adaptive、 Biotechnologies Corporation、 ArcherDX, Inc.、 Asuragen Inc.、 Arup Laboratories Inc.、 Bio-Rad Laboratories、 Opko Health、 Quest Diagnostics、 ICON plcなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、がん再発モニタリングキットのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のがん再発モニタリングキット市場：タイプ別、2018年-2023年、2024年-2029年
世界のがん再発モニタリングキット市場：タイプ別市場シェア、2022年
・血液がん、骨がん

世界のがん再発モニタリングキット市場：用途別、2018年-2023年、2024年-2029年
世界のがん再発モニタリングキット市場：用途別市場シェア、2022年
・病院、診療所

世界のがん再発モニタリングキット市場：地域・国別、2018年-2023年、2024年-2029年
世界のがん再発モニタリングキット市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるがん再発モニタリングキットのグローバル売上、2018年-2023年
・主要企業におけるがん再発モニタリングキットのグローバル売上シェア、2022年
・主要企業におけるがん再発モニタリングキットのグローバル販売量、2018年-2023年
・主要企業におけるがん再発モニタリングキットのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
SeekIn、 Guardant Health、 Neoimmune、 Labcorp Inc、 F.Hoffmann-La Roche Ltd.、 Cergentis B.V.、 Sysmex Corporation、 NeoGenomics Laboratories, Inc.、 Adaptive、 Biotechnologies Corporation、 ArcherDX, Inc.、 Asuragen Inc.、 Arup Laboratories Inc.、 Bio-Rad Laboratories、 Opko Health、 Quest Diagnostics、 ICON plc

*************************************************************

・調査・分析レポートの概要
がん再発モニタリングキット市場の定義
市場セグメント
世界のがん再発モニタリングキット市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のがん再発モニタリングキット市場規模
世界のがん再発モニタリングキット市場規模：2022年 VS 2029年
世界のがん再発モニタリングキット市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのがん再発モニタリングキットの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のがん再発モニタリングキット製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：血液がん、骨がん
がん再発モニタリングキットのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所
がん再発モニタリングキットの用途別グローバル売上・予測

・地域別市場分析
地域別がん再発モニタリングキット市場規模 2022年と2029年
地域別がん再発モニタリングキット売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
SeekIn、 Guardant Health、 Neoimmune、 Labcorp Inc、 F.Hoffmann-La Roche Ltd.、 Cergentis B.V.、 Sysmex Corporation、 NeoGenomics Laboratories, Inc.、 Adaptive、 Biotechnologies Corporation、 ArcherDX, Inc.、 Asuragen Inc.、 Arup Laboratories Inc.、 Bio-Rad Laboratories、 Opko Health、 Quest Diagnostics、 ICON plc
...

This research report provides a comprehensive analysis of the Cancer Recurrence Monitoring Kit market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cancer Recurrence Monitoring Kit market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cancer Recurrence Monitoring Kit, challenges faced by the industry, and potential opportunities for market players.
The global Cancer Recurrence Monitoring Kit market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cancer Recurrence Monitoring Kit market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cancer Recurrence Monitoring Kit market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cancer Recurrence Monitoring Kit market was valued at US$ 1433.6 million in 2022 and is projected to reach US$ 3273.9 million by 2029, at a CAGR of 12.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Cancer recurrence monitoring kit is one of the important products in the field of medical diagnosis and has a wide market demand. This market prospect continues to grow with increasing number of cancer patients and increasing pursuit of early diagnosis and treatment. The size and growth potential of the market may be affected by a variety of factors, including the increase in cancer patients, technological advancements, improvements in the healthcare system, etc.
Key Features:
The research report on the Cancer Recurrence Monitoring Kit market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cancer Recurrence Monitoring Kit market.
Market Overview: The report provides a comprehensive overview of the Cancer Recurrence Monitoring Kit market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Blood Cancer, Bone Cancer), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cancer Recurrence Monitoring Kit market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cancer Recurrence Monitoring Kit market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cancer Recurrence Monitoring Kit market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cancer Recurrence Monitoring Kit market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cancer Recurrence Monitoring Kit market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cancer Recurrence Monitoring Kit market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cancer Recurrence Monitoring Kit, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cancer Recurrence Monitoring Kit market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cancer Recurrence Monitoring Kit market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Blood Cancer
Bone Cancer
Market segment by Application
Hospital
Clinic
Global Cancer Recurrence Monitoring Kit Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
SeekIn
Guardant Health
Neoimmune
Labcorp Inc
F.Hoffmann-La Roche Ltd.
Cergentis B.V.
Sysmex Corporation
NeoGenomics Laboratories, Inc.
Adaptive
Biotechnologies Corporation
ArcherDX, Inc.
Asuragen Inc.
Arup Laboratories Inc.
Bio-Rad Laboratories
Opko Health
Quest Diagnostics
ICON plc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Recurrence Monitoring Kit, market overview.
Chapter 2: Global Cancer Recurrence Monitoring Kit market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Recurrence Monitoring Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Recurrence Monitoring Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Recurrence Monitoring Kit capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Cancer Recurrence Monitoring Kit Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Recurrence Monitoring Kit Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Recurrence Monitoring Kit Overall Market Size
2.1 Global Cancer Recurrence Monitoring Kit Market Size: 2022 VS 2029
2.2 Global Cancer Recurrence Monitoring Kit Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Cancer Recurrence Monitoring Kit Sales: 2018-2029
3 Company Landscape
3.1 Top Cancer Recurrence Monitoring Kit Players in Global Market
3.2 Top Global Cancer Recurrence Monitoring Kit Companies Ranked by Revenue
3.3 Global Cancer Recurrence Monitoring Kit Revenue by Companies
3.4 Global Cancer Recurrence Monitoring Kit Sales by Companies
3.5 Global Cancer Recurrence Monitoring Kit Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cancer Recurrence Monitoring Kit Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cancer Recurrence Monitoring Kit Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Recurrence Monitoring Kit Players in Global Market
3.8.1 List of Global Tier 1 Cancer Recurrence Monitoring Kit Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Recurrence Monitoring Kit Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Cancer Recurrence Monitoring Kit Market Size Markets, 2022 & 2029
4.1.2 Blood Cancer
4.1.3 Bone Cancer
4.2 By Type – Global Cancer Recurrence Monitoring Kit Revenue & Forecasts
4.2.1 By Type – Global Cancer Recurrence Monitoring Kit Revenue, 2018-2023
4.2.2 By Type – Global Cancer Recurrence Monitoring Kit Revenue, 2024-2029
4.2.3 By Type – Global Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
4.3 By Type – Global Cancer Recurrence Monitoring Kit Sales & Forecasts
4.3.1 By Type – Global Cancer Recurrence Monitoring Kit Sales, 2018-2023
4.3.2 By Type – Global Cancer Recurrence Monitoring Kit Sales, 2024-2029
4.3.3 By Type – Global Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
4.4 By Type – Global Cancer Recurrence Monitoring Kit Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cancer Recurrence Monitoring Kit Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application – Global Cancer Recurrence Monitoring Kit Revenue & Forecasts
5.2.1 By Application – Global Cancer Recurrence Monitoring Kit Revenue, 2018-2023
5.2.2 By Application – Global Cancer Recurrence Monitoring Kit Revenue, 2024-2029
5.2.3 By Application – Global Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
5.3 By Application – Global Cancer Recurrence Monitoring Kit Sales & Forecasts
5.3.1 By Application – Global Cancer Recurrence Monitoring Kit Sales, 2018-2023
5.3.2 By Application – Global Cancer Recurrence Monitoring Kit Sales, 2024-2029
5.3.3 By Application – Global Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
5.4 By Application – Global Cancer Recurrence Monitoring Kit Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Cancer Recurrence Monitoring Kit Market Size, 2022 & 2029
6.2 By Region – Global Cancer Recurrence Monitoring Kit Revenue & Forecasts
6.2.1 By Region – Global Cancer Recurrence Monitoring Kit Revenue, 2018-2023
6.2.2 By Region – Global Cancer Recurrence Monitoring Kit Revenue, 2024-2029
6.2.3 By Region – Global Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
6.3 By Region – Global Cancer Recurrence Monitoring Kit Sales & Forecasts
6.3.1 By Region – Global Cancer Recurrence Monitoring Kit Sales, 2018-2023
6.3.2 By Region – Global Cancer Recurrence Monitoring Kit Sales, 2024-2029
6.3.3 By Region – Global Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Cancer Recurrence Monitoring Kit Revenue, 2018-2029
6.4.2 By Country – North America Cancer Recurrence Monitoring Kit Sales, 2018-2029
6.4.3 US Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.4.4 Canada Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.4.5 Mexico Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Cancer Recurrence Monitoring Kit Revenue, 2018-2029
6.5.2 By Country – Europe Cancer Recurrence Monitoring Kit Sales, 2018-2029
6.5.3 Germany Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.4 France Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.5 U.K. Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.6 Italy Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.7 Russia Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.8 Nordic Countries Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.9 Benelux Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Cancer Recurrence Monitoring Kit Revenue, 2018-2029
6.6.2 By Region – Asia Cancer Recurrence Monitoring Kit Sales, 2018-2029
6.6.3 China Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.6.4 Japan Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.6.5 South Korea Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.6.6 Southeast Asia Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.6.7 India Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Cancer Recurrence Monitoring Kit Revenue, 2018-2029
6.7.2 By Country – South America Cancer Recurrence Monitoring Kit Sales, 2018-2029
6.7.3 Brazil Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.7.4 Argentina Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Cancer Recurrence Monitoring Kit Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Cancer Recurrence Monitoring Kit Sales, 2018-2029
6.8.3 Turkey Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.8.4 Israel Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.8.5 Saudi Arabia Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.8.6 UAE Cancer Recurrence Monitoring Kit Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 SeekIn
7.1.1 SeekIn Company Summary
7.1.2 SeekIn Business Overview
7.1.3 SeekIn Cancer Recurrence Monitoring Kit Major Product Offerings
7.1.4 SeekIn Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.1.5 SeekIn Key News & Latest Developments
7.2 Guardant Health
7.2.1 Guardant Health Company Summary
7.2.2 Guardant Health Business Overview
7.2.3 Guardant Health Cancer Recurrence Monitoring Kit Major Product Offerings
7.2.4 Guardant Health Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.2.5 Guardant Health Key News & Latest Developments
7.3 Neoimmune
7.3.1 Neoimmune Company Summary
7.3.2 Neoimmune Business Overview
7.3.3 Neoimmune Cancer Recurrence Monitoring Kit Major Product Offerings
7.3.4 Neoimmune Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.3.5 Neoimmune Key News & Latest Developments
7.4 Labcorp Inc
7.4.1 Labcorp Inc Company Summary
7.4.2 Labcorp Inc Business Overview
7.4.3 Labcorp Inc Cancer Recurrence Monitoring Kit Major Product Offerings
7.4.4 Labcorp Inc Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.4.5 Labcorp Inc Key News & Latest Developments
7.5 F.Hoffmann-La Roche Ltd.
7.5.1 F.Hoffmann-La Roche Ltd. Company Summary
7.5.2 F.Hoffmann-La Roche Ltd. Business Overview
7.5.3 F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Major Product Offerings
7.5.4 F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.5.5 F.Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 Cergentis B.V.
7.6.1 Cergentis B.V. Company Summary
7.6.2 Cergentis B.V. Business Overview
7.6.3 Cergentis B.V. Cancer Recurrence Monitoring Kit Major Product Offerings
7.6.4 Cergentis B.V. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.6.5 Cergentis B.V. Key News & Latest Developments
7.7 Sysmex Corporation
7.7.1 Sysmex Corporation Company Summary
7.7.2 Sysmex Corporation Business Overview
7.7.3 Sysmex Corporation Cancer Recurrence Monitoring Kit Major Product Offerings
7.7.4 Sysmex Corporation Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.7.5 Sysmex Corporation Key News & Latest Developments
7.8 NeoGenomics Laboratories, Inc.
7.8.1 NeoGenomics Laboratories, Inc. Company Summary
7.8.2 NeoGenomics Laboratories, Inc. Business Overview
7.8.3 NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Major Product Offerings
7.8.4 NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.8.5 NeoGenomics Laboratories, Inc. Key News & Latest Developments
7.9 Adaptive
7.9.1 Adaptive Company Summary
7.9.2 Adaptive Business Overview
7.9.3 Adaptive Cancer Recurrence Monitoring Kit Major Product Offerings
7.9.4 Adaptive Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.9.5 Adaptive Key News & Latest Developments
7.10 Biotechnologies Corporation
7.10.1 Biotechnologies Corporation Company Summary
7.10.2 Biotechnologies Corporation Business Overview
7.10.3 Biotechnologies Corporation Cancer Recurrence Monitoring Kit Major Product Offerings
7.10.4 Biotechnologies Corporation Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.10.5 Biotechnologies Corporation Key News & Latest Developments
7.11 ArcherDX, Inc.
7.11.1 ArcherDX, Inc. Company Summary
7.11.2 ArcherDX, Inc. Business Overview
7.11.3 ArcherDX, Inc. Cancer Recurrence Monitoring Kit Major Product Offerings
7.11.4 ArcherDX, Inc. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.11.5 ArcherDX, Inc. Key News & Latest Developments
7.12 Asuragen Inc.
7.12.1 Asuragen Inc. Company Summary
7.12.2 Asuragen Inc. Business Overview
7.12.3 Asuragen Inc. Cancer Recurrence Monitoring Kit Major Product Offerings
7.12.4 Asuragen Inc. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.12.5 Asuragen Inc. Key News & Latest Developments
7.13 Arup Laboratories Inc.
7.13.1 Arup Laboratories Inc. Company Summary
7.13.2 Arup Laboratories Inc. Business Overview
7.13.3 Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Major Product Offerings
7.13.4 Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.13.5 Arup Laboratories Inc. Key News & Latest Developments
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Company Summary
7.14.2 Bio-Rad Laboratories Business Overview
7.14.3 Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Major Product Offerings
7.14.4 Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.14.5 Bio-Rad Laboratories Key News & Latest Developments
7.15 Opko Health
7.15.1 Opko Health Company Summary
7.15.2 Opko Health Business Overview
7.15.3 Opko Health Cancer Recurrence Monitoring Kit Major Product Offerings
7.15.4 Opko Health Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.15.5 Opko Health Key News & Latest Developments
7.16 Quest Diagnostics
7.16.1 Quest Diagnostics Company Summary
7.16.2 Quest Diagnostics Business Overview
7.16.3 Quest Diagnostics Cancer Recurrence Monitoring Kit Major Product Offerings
7.16.4 Quest Diagnostics Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.16.5 Quest Diagnostics Key News & Latest Developments
7.17 ICON plc
7.17.1 ICON plc Company Summary
7.17.2 ICON plc Business Overview
7.17.3 ICON plc Cancer Recurrence Monitoring Kit Major Product Offerings
7.17.4 ICON plc Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.17.5 ICON plc Key News & Latest Developments
8 Global Cancer Recurrence Monitoring Kit Production Capacity, Analysis
8.1 Global Cancer Recurrence Monitoring Kit Production Capacity, 2018-2029
8.2 Cancer Recurrence Monitoring Kit Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Recurrence Monitoring Kit Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cancer Recurrence Monitoring Kit Supply Chain Analysis
10.1 Cancer Recurrence Monitoring Kit Industry Value Chain
10.2 Cancer Recurrence Monitoring Kit Upstream Market
10.3 Cancer Recurrence Monitoring Kit Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Recurrence Monitoring Kit Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Cancer Recurrence Monitoring Kit in Global Market
Table 2. Top Cancer Recurrence Monitoring Kit Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Cancer Recurrence Monitoring Kit Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Cancer Recurrence Monitoring Kit Revenue Share by Companies, 2018-2023
Table 5. Global Cancer Recurrence Monitoring Kit Sales by Companies, (K Units), 2018-2023
Table 6. Global Cancer Recurrence Monitoring Kit Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Cancer Recurrence Monitoring Kit Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Cancer Recurrence Monitoring Kit Product Type
Table 9. List of Global Tier 1 Cancer Recurrence Monitoring Kit Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Recurrence Monitoring Kit Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Cancer Recurrence Monitoring Kit Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Cancer Recurrence Monitoring Kit Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Cancer Recurrence Monitoring Kit Sales (K Units), 2018-2023
Table 15. By Type - Global Cancer Recurrence Monitoring Kit Sales (K Units), 2024-2029
Table 16. By Application – Global Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Cancer Recurrence Monitoring Kit Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Cancer Recurrence Monitoring Kit Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Cancer Recurrence Monitoring Kit Sales (K Units), 2018-2023
Table 20. By Application - Global Cancer Recurrence Monitoring Kit Sales (K Units), 2024-2029
Table 21. By Region – Global Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Cancer Recurrence Monitoring Kit Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Cancer Recurrence Monitoring Kit Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Cancer Recurrence Monitoring Kit Sales (K Units), 2018-2023
Table 25. By Region - Global Cancer Recurrence Monitoring Kit Sales (K Units), 2024-2029
Table 26. By Country - North America Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Cancer Recurrence Monitoring Kit Sales, (K Units), 2018-2023
Table 29. By Country - North America Cancer Recurrence Monitoring Kit Sales, (K Units), 2024-2029
Table 30. By Country - Europe Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Cancer Recurrence Monitoring Kit Sales, (K Units), 2018-2023
Table 33. By Country - Europe Cancer Recurrence Monitoring Kit Sales, (K Units), 2024-2029
Table 34. By Region - Asia Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Cancer Recurrence Monitoring Kit Sales, (K Units), 2018-2023
Table 37. By Region - Asia Cancer Recurrence Monitoring Kit Sales, (K Units), 2024-2029
Table 38. By Country - South America Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Cancer Recurrence Monitoring Kit Sales, (K Units), 2018-2023
Table 41. By Country - South America Cancer Recurrence Monitoring Kit Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Cancer Recurrence Monitoring Kit Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Cancer Recurrence Monitoring Kit Sales, (K Units), 2024-2029
Table 46. SeekIn Company Summary
Table 47. SeekIn Cancer Recurrence Monitoring Kit Product Offerings
Table 48. SeekIn Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. SeekIn Key News & Latest Developments
Table 50. Guardant Health Company Summary
Table 51. Guardant Health Cancer Recurrence Monitoring Kit Product Offerings
Table 52. Guardant Health Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Guardant Health Key News & Latest Developments
Table 54. Neoimmune Company Summary
Table 55. Neoimmune Cancer Recurrence Monitoring Kit Product Offerings
Table 56. Neoimmune Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Neoimmune Key News & Latest Developments
Table 58. Labcorp Inc Company Summary
Table 59. Labcorp Inc Cancer Recurrence Monitoring Kit Product Offerings
Table 60. Labcorp Inc Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Labcorp Inc Key News & Latest Developments
Table 62. F.Hoffmann-La Roche Ltd. Company Summary
Table 63. F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Product Offerings
Table 64. F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. F.Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 66. Cergentis B.V. Company Summary
Table 67. Cergentis B.V. Cancer Recurrence Monitoring Kit Product Offerings
Table 68. Cergentis B.V. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Cergentis B.V. Key News & Latest Developments
Table 70. Sysmex Corporation Company Summary
Table 71. Sysmex Corporation Cancer Recurrence Monitoring Kit Product Offerings
Table 72. Sysmex Corporation Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Sysmex Corporation Key News & Latest Developments
Table 74. NeoGenomics Laboratories, Inc. Company Summary
Table 75. NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Product Offerings
Table 76. NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. NeoGenomics Laboratories, Inc. Key News & Latest Developments
Table 78. Adaptive Company Summary
Table 79. Adaptive Cancer Recurrence Monitoring Kit Product Offerings
Table 80. Adaptive Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Adaptive Key News & Latest Developments
Table 82. Biotechnologies Corporation Company Summary
Table 83. Biotechnologies Corporation Cancer Recurrence Monitoring Kit Product Offerings
Table 84. Biotechnologies Corporation Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Biotechnologies Corporation Key News & Latest Developments
Table 86. ArcherDX, Inc. Company Summary
Table 87. ArcherDX, Inc. Cancer Recurrence Monitoring Kit Product Offerings
Table 88. ArcherDX, Inc. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. ArcherDX, Inc. Key News & Latest Developments
Table 90. Asuragen Inc. Company Summary
Table 91. Asuragen Inc. Cancer Recurrence Monitoring Kit Product Offerings
Table 92. Asuragen Inc. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Asuragen Inc. Key News & Latest Developments
Table 94. Arup Laboratories Inc. Company Summary
Table 95. Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Product Offerings
Table 96. Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Arup Laboratories Inc. Key News & Latest Developments
Table 98. Bio-Rad Laboratories Company Summary
Table 99. Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Product Offerings
Table 100. Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Bio-Rad Laboratories Key News & Latest Developments
Table 102. Opko Health Company Summary
Table 103. Opko Health Cancer Recurrence Monitoring Kit Product Offerings
Table 104. Opko Health Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Opko Health Key News & Latest Developments
Table 106. Quest Diagnostics Company Summary
Table 107. Quest Diagnostics Cancer Recurrence Monitoring Kit Product Offerings
Table 108. Quest Diagnostics Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Quest Diagnostics Key News & Latest Developments
Table 110. ICON plc Company Summary
Table 111. ICON plc Cancer Recurrence Monitoring Kit Product Offerings
Table 112. ICON plc Cancer Recurrence Monitoring Kit Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. ICON plc Key News & Latest Developments
Table 114. Cancer Recurrence Monitoring Kit Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 115. Global Cancer Recurrence Monitoring Kit Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Cancer Recurrence Monitoring Kit Production by Region, 2018-2023 (K Units)
Table 117. Global Cancer Recurrence Monitoring Kit Production by Region, 2024-2029 (K Units)
Table 118. Cancer Recurrence Monitoring Kit Market Opportunities & Trends in Global Market
Table 119. Cancer Recurrence Monitoring Kit Market Drivers in Global Market
Table 120. Cancer Recurrence Monitoring Kit Market Restraints in Global Market
Table 121. Cancer Recurrence Monitoring Kit Raw Materials
Table 122. Cancer Recurrence Monitoring Kit Raw Materials Suppliers in Global Market
Table 123. Typical Cancer Recurrence Monitoring Kit Downstream
Table 124. Cancer Recurrence Monitoring Kit Downstream Clients in Global Market
Table 125. Cancer Recurrence Monitoring Kit Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cancer Recurrence Monitoring Kit Segment by Type in 2022
Figure 2. Cancer Recurrence Monitoring Kit Segment by Application in 2022
Figure 3. Global Cancer Recurrence Monitoring Kit Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Recurrence Monitoring Kit Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Recurrence Monitoring Kit Revenue, 2018-2029 (US$, Mn)
Figure 7. Cancer Recurrence Monitoring Kit Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cancer Recurrence Monitoring Kit Revenue in 2022
Figure 9. By Type - Global Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
Figure 11. By Type - Global Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
Figure 12. By Type - Global Cancer Recurrence Monitoring Kit Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
Figure 15. By Application - Global Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
Figure 16. By Application - Global Cancer Recurrence Monitoring Kit Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Cancer Recurrence Monitoring Kit Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
Figure 20. By Region - Global Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
Figure 21. By Country - North America Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
Figure 22. By Country - North America Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
Figure 23. US Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
Figure 28. Germany Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 29. France Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
Figure 37. China Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 41. India Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
Figure 43. By Country - South America Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
Figure 44. Brazil Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
Figure 48. Turkey Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Cancer Recurrence Monitoring Kit Revenue, (US$, Mn), 2018-2029
Figure 52. Global Cancer Recurrence Monitoring Kit Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Cancer Recurrence Monitoring Kit by Region, 2022 VS 2029
Figure 54. Cancer Recurrence Monitoring Kit Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 抗がん剤曝露評価サービスのグローバル市場展望 2023年-2029年：がん標的治療薬、免疫療法薬、その他
  • 肝臓がんスクリーニング装置のグローバル市場展望 2023年-2029年：血液検査、画像検査
  • 乳がん標的療法のグローバル市場展望 2023年-2029年：ブランド医薬品、ジェネリック医薬品
  • がん放射線療法のグローバル市場展望 2023年-2029年：外照射療法、内照射療法、全身放射線療法、静脈内放射線療法、経口放射線療法、点滴放射線療法
  • がん薬物治療のグローバル市場展望 2023年-2029年：標的治療、化学治療、免疫治療
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC12725 )"がん再発モニタリングキットのグローバル市場展望 2023年-2029年：血液がん、骨がん" (英文：Cancer Recurrence Monitoring Kit Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。